Urology
Conditions
Brief summary
This study aims to evaluate the impact of reminder call intervention on no-shows for urologic procedures in patients identified to be high risk for no-showing. Patients scheduled to undergo a urologic procedure will be randomized into two groups: the intervention group, who receives a series of reminder calls and text messages about appointment details and patient questions prior to the procedure date; and the control group, who receives standard care only. Secondary outcomes include rates of patient re-scheduling and healthcare utilization.
Interventions
BEHAVIORALPreoperative Outreach
Participants will receive enhanced preoperative outreach consisting of reminder phone calls 7 days, 3 days, 1 day, and on the day of their scheduled urologic procedure, in addition to standard care. Calls will review appointment details, address patient questions, assess barriers to attendance, provide text-based communication access, and facilitate referral to social work when appropriate.
Sponsors
University of California, San Francisco
Study design
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE
Eligibility
Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No
Inclusion criteria
* Adults aged 18 years or older * Identified as high risk for no-show by the study predictive model * Scheduled to undergo a urologic procedure at UCSF/UCSF affiliated sites
Exclusion criteria
* Younger than 18 years of age * Not scheduled for a urologic procedure
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Procedure No-Show Rate | From enrollment until the scheduled procedure date (up to 8 weeks) | Whether the participant attended their scheduled urologic procedure |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Procedure Rescheduling Rate | From enrollment until the scheduled procedure date (up to 8 weeks) | Whether the participant rescheduled their procedure |
Countries
United States
Contacts
CONTACTDavid Bayne, MD
CONTACTDarren Chau
PRINCIPAL_INVESTIGATORDavid Bayne, MD
University of California, San Francisco
Outcome results
None listed